<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>25(1)</volume><submitter>Regmi NP</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>The Advisory Committee on Immunization Practices (ACIP) routinely recommends adolescents receive tetanus, diphtheria, and acellular pertussis (Tdap); meningococcal conjugate (MenACWY); and human papillomavirus (HPV) vaccines at age 11-12 years and routinely recommends influenza and COVID-19 vaccines annually for all adolescents, based on recommendations in 2023. We aimed to assess the overall proportion of US teens who are up-to-date (UTD) on receiving Tdap, MenACWY, and HPV vaccines by age 13 and the proportion who received seasonal influenza vaccine, the initial COVID-19 vaccination series and the initial COVID-19 booster. We also aimed to determine the relationship between multiple socio-demographic factors with the following: UTD status, and receipt of seasonal influ</pubmed_abstract><journal>BMC public health</journal><pagination>3094</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12461998</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Tdap, MenACWY, HPV, seasonal influenza, and COVID-19 vaccination status among US teens aged 13-17 years in 2022.</pubmed_title><pmcid>PMC12461998</pmcid><pubmed_authors>Basta NE</pubmed_authors><pubmed_authors>Huang Z</pubmed_authors><pubmed_authors>Sassi A</pubmed_authors><pubmed_authors>Ulrich AK</pubmed_authors><pubmed_authors>Regmi NP</pubmed_authors></additional><is_claimable>false</is_claimable><name>Tdap, MenACWY, HPV, seasonal influenza, and COVID-19 vaccination status among US teens aged 13-17 years in 2022.</name><description>&lt;h4>Background&lt;/h4>The Advisory Committee on Immunization Practices (ACIP) routinely recommends adolescents receive tetanus, diphtheria, and acellular pertussis (Tdap); meningococcal conjugate (MenACWY); and human papillomavirus (HPV) vaccines at age 11-12 years and routinely recommends influenza and COVID-19 vaccines annually for all adolescents, based on recommendations in 2023. We aimed to assess the overall proportion of US teens who are up-to-date (UTD) on receiving Tdap, MenACWY, and HPV vaccines by age 13 and the proportion who received seasonal influenza vaccine, the initial COVID-19 vaccination series and the initial COVID-19 booster. We also aimed to determine the relationship between multiple socio-demographic factors with the following: UTD status, and receipt of seasonal influ</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Sep</publication><modification>2026-06-03T20:31:47.385Z</modification><creation>2026-05-01T03:10:54.259Z</creation></dates><accession>S-EPMC12461998</accession><cross_references><pubmed>40993753</pubmed><doi>10.1186/s12889-025-24434-0</doi></cross_references></HashMap>